ArcelorMittal, Marcegaglia Make Offer For Italy's Ilva Steel Plant
ArcelorMittal and Italy's Marcegaglia have made an offer to buy Italy's beleaguered Ilva steel plant, promising to invest 2.3 billion euros ($2.4 billion) and boost production, ArcelorMittal said on Monday.
Italy took over the loss-making Ilva plant, Europe's largest by capacity, in 2015 to save thousands of jobs and clean up the polluted site in the southern Italian city of Taranto.
Large portions of the factory were sequestered by magistrates in 2013 on accusations that owners were responsible for an environmental disaster.
A rival offer by a consortium that includes India's JSW Steel and state holding company lender Cassa Depositi e Prestiti is expected to be announced later on Monday.
The government is expected to say which offer it will accept in about a month's time.
The government wants a buyer that will restore the factory's fortunes by cleaning it up and investing to make it economically viable in a region with soaring unemployment.
Intesa Sanpaolo, Italy's biggest retail bank, signed a letter of intent along with ArcelorMittal, the world's largest steelmaker, and Marcegaglia, a family-run steel processing group. The value of the offer was not given.
The consortium said it would boost output with low-carbon steel-making technologies, ultimately up to 9.5 million tonnes of finished products from less than 6 million tonnes now. It also said it would create a research and development centre with an initial investment of 10 million euros.
"It has been sad to watch the decline of this great company in recent years and we are excited to have the chance to contribute to a new renaissance of this Italian steel icon," Marcegaglia's chairman and chief executive, Antonio Marcegaglia, said in a statement.
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.